ABUS
NASDAQ · Biotechnology
Arbutus Biopharma Corp
$4.34
-0.01 (-0.23%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,080.9% upside
Low Target
$34.47
Average Target
$51.25
High Target
$59.24
Current Price
$4.34
Current
$4.34
$4.34
Target
$51.25
$51.25
$34.47
$51.25 avg
$59.24
Scenario Analysis
Bear Case
$34.47
694.2%
Low target
Base Case
$51.25
+1,080.9%
Avg target
Bull Case
$59.24
+1,265.0%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$5.10
-14.9% from high
52-Week Low
$2.94
+47.6% from low
Target vs 52W High
$51.25
+904.9% vs high
Next Earnings Report
May 12, 2026
1d
tomorrow
EPS Est: $-0.03
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |